Krystal Biotech (KRYS) Receives a Buy from Bank of America Securities
In a report released today, Alec Stranahan from Bank of America Securities reiterated a Buy rating on Krystal Biotech (KRYS – Research Report), ...
Hosted on MSN12mon
Krystal Biotech, Candel, Edgewise gain after FDA fast track tags
Krystal Biotech (NASDAQ:KRYS), Candel Therapeutics (NASDAQ:CADL), and Edgewise Therapeutics (NASDAQ:EWTX) were among the notable gainers in the biopharma space on Tuesday premarket after the U.S ...
Hosted on MSN1mon
KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707
Krystal Biotech KRYS announced encouraging ... In the past 60 days, estimates for CytomX Therapeutics’ 2024 loss per share have narrowed from 29 cents to 5 cents. Estimates for 2025 loss per ...
Business Insider28d
Crispr Therapeutics AG (CRSP) Receives a Buy from Bank of America Securities
Crispr Therapeutics AG, and Krystal Biotech. According to TipRanks, Stranahan has an average return of -9.4% and a 35.76% success rate on recommended stocks. Crispr Therapeutics AG has an analyst ...
Business Wire1mon
City Therapeutics Appoints Andy Orth as Chief Executive Officer
About Andy Orth, Chief Executive Officer Prior to joining City Therapeutics, Mr. Orth served as chief commercial officer of Krystal Biotech, where he drove company strategy and growth, and oversaw ...